Does olanzapine inhibit the psychomimetic effects of Delta(9)-tetrahydrocannabinol?

Kleinloog, D.; Liem-Moolenaar, M.; Jacobs, G.; Klaassen, E.; Kam, M. de; Hijman, R.; Gerven, J. van (2012)

Article / Letter to editor

• Tetrahydrocannabinol
• olanzapine
• clinical pharmacology
• psychological model
• biological model
• human volunteers
• psychiatric status rating scales
• psychotic disorders
• schizophrenia
• psychosis model

• All authors: Kleinloog, D.; Liem-Moolenaar, M.; Jacobs, G.; Klaassen, E.; Kam, M. de; Hijman, R.; Gerven, J. van
• Date: 2012-10-31
• Journal: Journal of Psychopharmacology
• Volume: 26
• Issue: 10
• Pages: 1307 - 1316
• DOI: doi:10.1177/0269881112446534